[Hyderabad, May 15th, 2025] – The global genomics market is undergoing an unprecedented transformation, projected to grow from USD 23.8 billion in 2024 to USD 54.2 billion by 2031, according to ClearView Market Insights’ 340-page genome-scale analysis.
Request Sample @ https://clearviewmarketinsights.com/report-details/global-genomics-market/
- The Clinical Genomics Revolution
- Cancer Diagnostics:
- 38% of oncology spend now on genomic testing
- Guardant's liquid biopsy detects 92% of Stage I cancers - Rare Disease Solutions:
- 5-year diagnostic odysseys reduced to 11 weeks
- 78% cost reduction since 2019
- The CRISPR Therapy Tipping Point
- Sickle Cell Cure:
- Vertex's exa-cel shows 89% efficacy
- USD 2M price tag sparks reimbursement wars - Agricultural Breakthroughs:
- Corteva's drought-resistant wheat increases yields by 38%
- The Data Deluge Challenge
- Storage Needs:
- 40 exabytes of genomic data by 2031
- Google's DeepVariant reduces compute costs by 72%
About ClearView Market Insights
ClearView Market Insights is a globally recognized research firm specializing in industrial automation, logistics, and smart manufacturing. Our reports provide data-driven insights to help businesses navigate evolving markets.
For more insights, visit https://clearviewmarketinsights.com/
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
